Retinal Dystrophies

21 clinical trials · Condition

Record	Firm	Date
Natural History of PRPF31 Mutation-Associated Retinal Dystrophy (NCT05573984)	PYC Therapeutics	2022-07-07
Efficacy and Safety of MCO-010 Optogenetic Therapy in Adults With Retinitis Pigmentosa [RESTORE] (NCT04945772)	Nanoscope Therapeutics Inc.	2021-07-13
EyeConic: Qualification for Cone-Optogenetics (NCT05294978)	Institute of Molecular and Clinical Ophthalmology Basel	2021-07-01
An Open-label, Dose Escalation and Double-masked, Randomized, Controlled Trial Evaluating Safety and Tolerability of Sepofarsen in Children (<8 Years of Age) With LCA10 Caused by Mutations in the CEP290 Gene. (NCT04855045)	ProQR Therapeutics	2021-03-23
A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO Gene (NCT04123626)	ProQR Therapeutics	2019-10-07
Performance of Long-wavelength Autofluorescence Imaging (NCT03592017)	Oxford University Hospitals NHS Trust	2018-10-01
Optical Head-Mounted Display Technology for Low Vision Rehabilitation (NCT02983305)	University of Michigan	2017-06-26
Intravitreal Ranibizumab (Lucentis®) in the Treatment of Non-leaking Macular Cysts in Retinal Dystrophy (NCT03763227)	Sultan Qaboos University	2015-07-24
iPS Cells of Patients for Models of Retinal Dystrophies (NCT03853252)	University Hospital, Montpellier	2014-11-03
Evaluation of Objective Perimetry Using Chromatic Multifocal Pupillometer (NCT02014389)	Sheba Medical Center	2013-12-01
Retinal Imaging by Adaptive Optics in Healthy Eyes and During Retinal and General Diseases (NCT01546181)	Institut National de la Santé Et de la Recherche Médicale, France	2010-10-01

Track Retinal Dystrophies automatically

Every clearance here is in the API, with alerts when new ones post.